Doctor of Osteopathy Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Samara Shipon

Anesthesiology Phoenix, AZ Doctor of Osteopathy

NPI 1487893152 CMS profile 67498

1850 N Central Ave, Suite 1600, Phoenix, AZ 85004

Open in the dashboard

General payments

$5,926

146 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Samara Shipon of Phoenix, AZ is reported in the CMS Open Payments database as having received $5,926 across 146 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $354 6
2022 General $54 3
2021 General $184 4
2020 General $434 18
2019 General $4,899 115

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Samara Shipon
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Samara Shipon were reported at $0. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Samara Shipon Anesthesiology median Middle half National median
2019 $4,899 $72 $23–$151 $163
2020 $434 $36 $17–$120 $114
2021 $184 $49 $21–$135 $132
2022 $54 $52 $22–$144 $149
2023 $354 $53 $23–$143 $160
2024 $0 $55 $25–$150 $164
2025 $0 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Vertiflex, Inc. $1,788 12 payments
  2. Medtronic USA, Inc. $1,534 19 payments
  3. Boston Scientific Corporation $565 32 payments
  4. Abbott Laboratories $526 19 payments
  5. TerSera Therapeutics LLC $172 5 payments
  6. Nevro Corp. $156 2 payments
  7. Scilex Pharmaceuticals Inc. $147 8 payments
  8. Avanos Medical $146 1 payment
  9. Lilly USA, LLC $138 6 payments
  10. Medtronic, Inc. $108 2 payments
  11. Other $645 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $3,838 139 payments
  2. Travel and Lodging $2,087 7 payments
Products named General payments · program years 2019–2023
  1. Superion ISS $1,788 12 payments
  2. ACTIVOS $986 6 payments
  3. INTELLIS $358 7 payments
  4. GENERAL PAIN MANAGEMENT $305 11 payments
  5. PRIALT $172 5 payments
  6. OSTEOCOOL RF ABLATION $152 3 payments
  7. COOLIEF* COOLED RADIOFREQUENCY $146 1 payment
  8. Proclaim IPG $146 2 payments
  9. Senza $143 1 payment
  10. Protege Family of SCS IPGs $115 2 payments
  11. Other $1,586 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record